6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9 PF-07321332 Boceprevir Intermediate

Short Description:

Chemical Name: 6,6-Dimethyl-3-azabicyclo[3.1.0]hexane

CAS: 943516-54-9

Appearance: Colorless Transparent Liquid

Purity: ≥98.0%

Intermediate of PF-07321332 Paxlovid (CAS 2628280-40-8) and Boceprevir (CAS 394730-60-0)

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Commercial Supply PF-07321332 Paxlovid Related Intermediates with High Quality
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9

Chemical Properties:

Chemical Name	6,6-Dimethyl-3-azabicyclo[3.1.0]hexane
CAS Number	943516-54-9
CAT Number	RF-PI316
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C7H13N
Molecular Weight	111.18
Boiling Point	135℃
Density	0.911
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Colorless Transparent Liquid
Purity	≥98.0%
Single Impurity	≤0.50%
Total Impurities	≤2.0%
Heavy Metals	≤20ppm
Test Standard	Enterprise Standard
Usage	Intermediate of PF-07321332 Paxlovid (CAS 2628280-40-8) and Boceprevir (CAS 394730-60-0)

Package & Storage:

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

FAQ:

Application:

6,6-Dimethyl-3-azabicyclo[3.1.0]hexane (CAS 943516-54-9) is the intermediate of PF-07321332 Paxlovid (CAS 2628280-40-8) and Boceprevir (CAS 394730-60-0). Pfizer's Paxlovid PF-07321332 is an oral antiviral therapeutic targeting the SARS-CoV-2 betacoronavirus to prevent COVID-19. Paxlovid is a protease inhibitor that has demonstrated potent in vitro antiviral activity against SARS-CoV-2 and other coronaviruses, suggesting potential for use in the treatment of COVID-19, as well as potential use against future virus threats, says Pfizer. Boceprevir (EBP 520) is a potent, highly selective, orally bioavailable HCV NS3 protease inhibitor with a Ki of 14 nM in both enzyme assay and an EC90 of 350 nM in cell-based replicon assay. Boceprevir inhibits SARS-CoV-2 3CLpro activity.